Dawn L. Wydner
FDA investigator
Appears on 1 document from 2009, mostly at sites in New Jersey. Most often cites current good tissue practice requirements (21 CFR 1271.150(c)(1)(iii)).
- 1
- Documents on file
- 7.0
- Observations per 483
- 2009
- First seen
- 2009
- Most recent
What they cite most
From 7 observations- 21 CFR 1271.150(c)(1)(iii)Current good tissue practice requirements1
- 21 CFR 1271.195(c)Environmental control and monitoring1
- 21 CFR 1271.220(c)Processing and process controls1
- 21 CFR 1271.230(b)Process validation1
- 21 CFR 1271.260(a)Storage1
- 21 CFR 820.100(b)Corrective and preventive action1
Activity by year
2009: 1
Where
New Jersey 1
Often inspects with
Is Dawn L. Wydner coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2009-03-13 | 483 Musculoskeletal Transplant FoundationMar 13, 2009 · Edison, New Jersey | Edison, New Jersey | 7 |
About this profile
What does Dawn L. Wydner inspect?
Dawn L. Wydner appears on 1 document on file covering 1 site, mostly in New Jersey.
What do they cite most often?
21 CFR 1271.150(c)(1)(iii) (current good tissue practice requirements), followed by 21 CFR 1271.195(c) and 21 CFR 1271.220(c).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Dawn L. Wydner is dated Mar 13, 2009.